ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
64 113,50
1,11%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Actualités

AXGN Axogen Inc

6,63
0,11 (1,69%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Axogen Inc AXGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,11 1,69% 6,63 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,53 6,4301 6,70 6,63 6,52
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
16/4/202413:00GLOBEAxogen, Inc. to Report First Quarter 2024 Financial Results..
08/3/202423:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:38EDGAR2Form 8-K - Current report
08/3/202400:12EDGAR2Form 144 - Report of proposed sale of securities
07/3/202422:18EDGAR2Form 144 - Report of proposed sale of securities
06/3/202414:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/3/202414:53EDGAR2Form S-3 - Registration statement under Securities Act of..
06/3/202414:45EDGAR2Form POS AM - Post-Effective amendments for registration..
05/3/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:29EDGAR2Form 8-K - Current report
05/3/202413:16EDGAR2Form 8-K - Current report
05/3/202413:00GLOBEAxogen, Inc Reports 2023 Fourth Quarter and Full-Year..
23/2/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202421:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:30GLOBEAxogen, Inc. to Report 2023 Fourth Quarter and Full-Year..
12/2/202419:21EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/2/202423:06EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:15GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
02/2/202415:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
18/1/202423:00GLOBEAxogen, Inc. Announces Positive Topline Results from REPOSE,..
11/1/202423:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202423:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/1/202423:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202413:05EDGAR2Form 8-K - Current report
05/1/202423:21EDGAR2Form 8-K/A - Current report: [Amend]
04/1/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202423:45EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/1/202422:56EDGAR2Form 8-K - Current report
04/1/202422:45GLOBEAxogen Reports Preliminary Unaudited Revenue for Fourth..
04/1/202422:40GLOBEAxogen Announces Plan for Leadership Transition with CEO..
04/1/202422:35GLOBEAxogen Announces Promotions on Research and Development Team
26/12/202322:21EDGAR2Form 8-K - Current report
26/12/202322:15GLOBEAxogen, Inc. Appoints Kathy Weiler to its Board of Directors
13/12/202322:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202322:38EDGAR2Form 144 - Report of proposed sale of securities
06/12/202313:15EDGAR2Form 8-K - Current report
06/12/202313:00GLOBEAxogen Announces Transition of Finance Team Leadership
01/12/202323:00GLOBECompany Reports Inducement Grants Under Nasdaq Listing Rule..
20/11/202313:00GLOBEAxogen, Inc. to Participate at the Piper Sandler 35th Annual..
07/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202313:13EDGAR2Form 8-K - Current report
07/11/202313:00GLOBEAxogen, Inc. Reports 2023 Third Quarter Financial Results
18/10/202313:00GLOBEAxogen, Inc. to Report Third Quarter 2023 Financial Results..
14/10/202302:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202302:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/10/202302:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Dernières Valeurs Consultées

NASDAQ
AXGN
Axogen
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés